Recon: FDA OKs Geron’s anemia therapy for specific cancer patients; Moderna reports positive Phase 3 results for COVID/flu combo
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States